Novo Nordisk Stock Rises on Trial Results for Cagrilintide Obesity Treatment US$ 22.44 Min. order: 1 piece ★★★★★ 4.8 (64 reviews) Sold : Login>>
Novo Nosedives on Underwhelming CagriSema Phase III Weight-Loss Data US$ 25.70 Min. order: 1 piece ★★★★★ 4.0 (67 reviews) Sold : Login>>
Novo Nordisk's next-gen obesity drug CagriSema trial results disappoint investors US$ 24.50 Min. order: 1 piece ★★★★★ 5.0 (236 reviews) Sold : Login>>
Has anyone tried BCP-157 injections for MS? US$ 27.25 Min. order: 1 piece ★★★★★ 4.7 (265 reviews) Sold : Login>>
Novo Nordisk advances obesity candidate to late-stage program after weight loss of less than 12% US$ 23.78 Min. order: 1 piece ★★★★★ 4.8 (224 reviews) Sold : Login>>